FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression

Journal of Affective Disorders

Volumn 185, Issue , 2015, Pages 164-169

  Santos, Marlene ^a,b,c   Carvalho, Serafim ^d,e   Lima, Luís ^a,b   Mota Pereira, Jorge ^f   Pimentel, Paulo ^g   Maia, Dulce ^g   Correia, Diana ^d   Gomes, Sofia ^d   Cruz, Agostinho ^b   Medeiros, Rui ^a,h,i,j  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^c University of Porto   (Portugal)

^d Institute of Biomedical Sciences Abel Salazar   (Portugal)

^e UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^f Clínica Médico Psiquiátrica da Ordem   (Portugal)

^g Trás os Montes e Alto Douro Central Hospital   (Portugal)

^h UNIVERSITY OF PORTO   (Portugal)

ⁱ UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^j Portuguese League Against Cancer (Norte)   (Portugal)

more..

Author keywords

Antidepressants; FAS; Neurogenesis; Neuroplasticity; Polymorphisms; Treatment Resistant Depression

Indexed keywords

ANTIDEPRESSANT AGENT; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; FAS PROTEIN, HUMAN; FASLG PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK;

ADULT; ALLELES; ANTIGENS, CD95; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FAS LIGAND PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 84955453477     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.06.027     Document Type: Article

References (36)

1. P.C. Banzato, S. Daher, E. Traina, M.R. Torloni, B.Y. Gueuvoghlanian-Silva, R.F. Puccini, K.P. Pendeloski, R. Mattar FAS and FAS-L genotype and expression in patients with recurrent pregnancy loss Reprod. Sci. 20 2013 1111 1115
2. O. Barca, M. Seoane, R.M. Senaris, V.M. Arce Fas/CD95 ligation induces proliferation of primary fetal astrocytes through a mechanism involving caspase 8-mediated ERK activation Cell 32 2013 111 120
3. C.P. Beier, J.B. Schulz CD95/Fas in the brain - not just a killer Cell Stem Cell 5 2009 128 130
4. S.A.D. Carvalho Variáveis Sócio-Cognitivas como Preditores da Resposta ao Tratamento Farmacológico da Depressão 2012 Universidade de Coimbra Coimbra
5. N.S. Corsini, I. Sancho-Martinez, S. Laudenklos, D. Glagow, S. Kumar, E. Letellier, P. Koch, M. Teodorczyk, S. Kleber, S. Klussmann, B. Wiestler, O. Brustle, W. Mueller, C. Gieffers, O. Hill, M. Thiemann, M. Seedorf, N. Gretz, R. Sprengel, T. Celikel, A. Martin-Villalba The death receptor CD95 activates adult neural stem cells for working memory formation and brain repair Cell Stem Cell 5 2009 178 190
6. J. Desbarats, R.B. Birge, M. Mimouni-Rongy, D.E. Weinstein, J.S. Palerme, M.K. Newell Fas engagement induces neurite growth through ERK activation and p35 upregulation Nat. Cell Biol. 5 2003 118 125
7. R.S. Duman Depression: a case of neuronal life and death? Biol. Psychiatry 56 2004 140 145
8. R.S. Duman, L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol. Psychiatry 59 2006 1116 1127
9. D. Erten-Lyons, A. Jacobson, P. Kramer, A. Grupe, J. Kaye The FAS gene, brain volume, and disease progression in Alzheimer's disease Alzheimer's Demen.: J. Alzheimer's Assoc. 6 2010 118 124
10. A. Frazer, S. Benmansour Delayed pharmacological effects of antidepressants Mol. Psychiatry 7 Suppl 1 2002 S23 S28
11. M.E. Guicciardi, G.J. Gores Life and death by death receptors FASEB J. 23 2009 1625 1637
12. W. Han, Y. Zhou, R. Zhong, C. Wu, R. Song, L. Liu, L. Zou, Y. Qiao, K. Zhai, J. Chang, L. Huang, L. Liu, X. Lu, J. Lou, D. Yu, W. Tan, J. Zhang, H. Wang, X. Miao Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population PloS one 8 2013 e71656
13. Q.R. Huang, D. Morris, N. Manolios Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene Mol. immunol. 34 1997 577 582
14. P. Jia, K. Jayathilake, Z. Zhao, H.Y. Meltzer Association of FAS, a TNF-alpha receptor gene, with treatment resistant schizophrenia Schizophr. Res. 129 2011 211 212
15. S. Kanemitsu, K. Ihara, A. Saifddin, T. Otsuka, T. Takeuchi, J. Nagayama, M. Kuwano, T. Hara A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus J. Rheumatol. 29 2002 1183 1188
16. S. Kleber, I. Sancho-Martinez, B. Wiestler, A. Beisel, C. Gieffers, O. Hill, M. Thiemann, W. Mueller, J. Sykora, A. Kuhn, N. Schreglmann, E. Letellier, C. Zuliani, S. Klussmann, M. Teodorczyk, H.J. Grone, T.M. Ganten, H. Sultmann, J. Tuttenberg, A. von Deimling, A. Regnier-Vigouroux, C. Herold-Mende, A. Martin-Villalba Yes and PI3K bind CD95 to signal invasion of glioblastoma Cancer cell 13 2008 235 248
17. C. Lambert, A.M. Landau, J. Desbarats Fas-beyond death: a regenerative role for Fas in the nervous system Apoptosis: Int. J. Program Cell Death 8 2003 551 562
18. L. Lima, J.A. Ferreira, A. Tavares, D. Oliveira, A. Morais, P.A. Videira, R. Medeiros, L. Santos FASL polymorphism is associated with response to bacillus Calmette-Guerin immunotherapy in bladder cancer Urol. oncology 32 44 2014 e41 47
19. J.E. Malberg Implications of adult hippocampal neurogenesis in antidepressant action J. Psychiatry Neurosci 29 2004 196 205
20. J.E. Malberg, A.J. Eisch, E.J. Nestler, R.S. Duman Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J. Neurosci 20 2000 9104 9110
21. Y. Oshimi, S. Oda, Y. Honda, S. Nagata, S. Miyazaki Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells J. Immunol. 157 1996 2909 2915
22. M.W. Pfaffl, G.W. Horgan, L. Dempfle Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res. 30 2002 e36
23. F. Pilar-Cuellar, R. Vidal, A. Diaz, E. Castro, S. dos Anjos, J. Pascual-Brazo, R. Linge, V. Vargas, H. Blanco, B. Martinez-Villayandre, A. Pazos, E.M. Valdizan Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication Neural Plast. 2013 2013 537265
24. L. Santarelli, M. Saxe, C. Gross, A. Surget, F. Battaglia, S. Dulawa, N. Weisstaub, J. Lee, R. Duman, O. Arancio, C. Belzung, R. Hen Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 805 809
25. K. Sibley, S. Rollinson, J.M. Allan, A.G. Smith, G.R. Law, P.L. Roddam, C.F. Skibola, M.T. Smith, G.J. Morgan Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia Cancer Res. 63 2003 4327 4330
26. T. Suda, T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, S. Nagata Expression of the Fas ligand in cells of T cell lineage J. immunol. 154 1995 3806 3813
27. T. Suda, T. Takahashi, S. Nagata Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1993 1169 1178
28. B. Trauth, C. Klas, W. Falk Monoclonal antibody-mediated tumor regression by induction of apoptosis Science 245 1989 301 305
29. M.H. Trivedi, A.J. Rush, M.L. Crismon, T.M. Kashner, M.G. Toprac, T.J. Carmody, T. Key, M.M. Biggs, K. Shores-Wilson, B. Witte, T. Suppes, A.L. Miller, K.Z. Altshuler, S.P. Shon Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project Archives of general psychiatry 61 2004 669 680
30. H. Wajant, K. Pfizenmaier, P. Scheurich Non-apoptotic Fas signaling Cytokine 14 2003 53 66
31. J.W. Wang, D.J. David, J.E. Monckton, F. Battaglia, R. Hen Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells J. Neurosci 28 2008 1374 1384
32. J. Wu, C. Metz, X. Xu, R. Abe, A.W. Gibson, J.C. Edberg, J. Cooke, F. Xie, G.S. Cooper, R.P. Kimberly A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients J. Immunol. 170 2003 132 138
33. Z. Xia, J.W. DePierre, L. Nassberger Dysregulation of bcl-2, c-myc, and Fas expression during tricyclic antidepressant-induced apoptosis in human peripheral lymphocytes J. Biochem. Toxicol 11 1996 203 204
34. Z. Zhang, L. Qiu, M. Wang, N. Tong, J. Li The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies Eur. J. Hum. Genet. 17 2009 1294 1303
35. Z. Zhang, H. Xue, W. Gong, M. Wang, L. Yuan, S. Han FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies Carcinogenesis 30 2009 487 493
36. C. Zuliani, S. Kleber, S. Klussmann, T. Wenger, M. Kenzelmann, N. Schreglmann, A. Martinez, J.A. del Rio, E. Soriano, P. Vodrazka, R. Kuner, H.J. Groene, I. Herr, P.H. Krammer, A. Martin-Villalba Control of neuronal branching by the death receptor CD95 (Fas/Apo-1) Cell Death Differ. 13 2006 31 40